Gillian Hunter

643 total citations
23 papers, 327 citations indexed

About

Gillian Hunter is a scholar working on Physiology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Gillian Hunter has authored 23 papers receiving a total of 327 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Physiology, 8 papers in Surgery and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Gillian Hunter's work include Asthma and respiratory diseases (14 papers), Neurogenetic and Muscular Disorders Research (7 papers) and RNA modifications and cancer (6 papers). Gillian Hunter is often cited by papers focused on Asthma and respiratory diseases (14 papers), Neurogenetic and Muscular Disorders Research (7 papers) and RNA modifications and cancer (6 papers). Gillian Hunter collaborates with scholars based in United Kingdom, United States and Germany. Gillian Hunter's co-authors include Thomas H. Gillingwater, Thomas M. Wishart, Sarah L. Roche, Rachael A. Powis, Chantal A. Mutsaers, Douglas J. Lamont, Ewout J. N. Groen, Ross A. Jones, Maica Llavero Hurtado and Laura C. Graham and has published in prestigious journals such as Journal of Allergy and Clinical Immunology, Human Molecular Genetics and European Respiratory Journal.

In The Last Decade

Gillian Hunter

23 papers receiving 317 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gillian Hunter United Kingdom 9 215 193 77 66 30 23 327
Verena Matejas Germany 10 215 1.0× 67 0.3× 82 1.1× 14 0.2× 21 0.7× 12 411
Chantal A. Mutsaers United Kingdom 8 300 1.4× 269 1.4× 46 0.6× 94 1.4× 12 0.4× 9 460
Robert Fey United States 5 268 1.2× 112 0.6× 14 0.2× 30 0.5× 19 0.6× 6 331
Silvia Spena Italy 13 185 0.9× 45 0.2× 104 1.4× 65 1.0× 178 5.9× 25 527
Florian Barthélémy United States 11 356 1.7× 52 0.3× 48 0.6× 44 0.7× 6 0.2× 24 447
Miko Valori Finland 8 43 0.2× 33 0.2× 50 0.6× 18 0.3× 15 0.5× 18 192
Greet Dijkman Netherlands 17 220 1.0× 39 0.2× 12 0.2× 20 0.3× 48 1.6× 27 886
Cristina Villanueva‐Mendoza Mexico 12 223 1.0× 44 0.2× 23 0.3× 44 0.7× 20 0.7× 34 361
Beate Mitulla Germany 10 187 0.9× 102 0.5× 13 0.2× 160 2.4× 37 1.2× 13 477
Eliza A. Gaylord United States 8 117 0.5× 27 0.1× 103 1.3× 34 0.5× 19 0.6× 11 267

Countries citing papers authored by Gillian Hunter

Since Specialization
Citations

This map shows the geographic impact of Gillian Hunter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gillian Hunter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gillian Hunter more than expected).

Fields of papers citing papers by Gillian Hunter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gillian Hunter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gillian Hunter. The network helps show where Gillian Hunter may publish in the future.

Co-authorship network of co-authors of Gillian Hunter

This figure shows the co-authorship network connecting the top 25 collaborators of Gillian Hunter. A scholar is included among the top collaborators of Gillian Hunter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gillian Hunter. Gillian Hunter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wechsler, Michael E., Guy Brusselle, J. Christian Virchow, et al.. (2024). Clinical response and on-treatment clinical remission with tezepelumab in a broad population of patients with severe, uncontrolled asthma: results over 2 years from the NAVIGATOR and DESTINATION studies. European Respiratory Journal. 64(6). 2400316–2400316. 19 indexed citations
2.
Lundahl, Anna, Jonathan Grigg, Gillian Hunter, et al.. (2024). Pharmacokinetics, pharmacodynamics and safety of tezepelumab in children with asthma. PA3562–PA3562. 1 indexed citations
3.
Menzies‐Gow, Andrew, Christopher S. Ambrose, Gene Colice, et al.. (2023). Effect of Tezepelumab on Lung Function in Patients With Severe, Uncontrolled Asthma in the Phase 3 NAVIGATOR Study. Advances in Therapy. 40(11). 4957–4971. 9 indexed citations
4.
5.
6.
Bernstein, Jonathan A., Jean‐Pierre Llanos, Gillian Hunter, Neil Martin, & Christopher S. Ambrose. (2023). Efficacy of Biologics in Patients with Allergic Severe Asthma, Overall and by Blood Eosinophil Count: A Literature Review. Advances in Therapy. 40(11). 4721–4740. 8 indexed citations
7.
Brusselle, Guy, JC Virchow, Liam G. Heaney, et al.. (2023). M21 On-treatment clinical remission with tezepelumab in patients with severe, uncontrolled asthma in the phase 3 DESTINATION study. A272–A273. 3 indexed citations
8.
Menzies‐Gow, Andrew, Arnaud Bourdin, Geoffrey Chupp, et al.. (2023). Effect of tezepelumab on healthcare utilization in patients with severe, uncontrolled asthma. Annals of Allergy Asthma & Immunology. 131(3). 343–348.e2. 4 indexed citations
9.
Wechsler, Michael E., Guy Brusselle, J. Christian Virchow, et al.. (2023). On-treatment clinical remission with tezepelumab in patients with severe, uncontrolled asthma in the phase 3 DESTINATION study. PA4722–PA4722. 1 indexed citations
10.
Brusselle, Guy, et al.. (2022). Efficacy of tezepelumab according to age at asthma onset in NAVIGATOR. 1835–1835. 1 indexed citations
11.
12.
Menzies‐Gow, Andrew, Jonathan Corren, Elliot Israel, et al.. (2021). Tezepelumab efficacy in patients with severe, uncontrolled asthma and comorbid nasal polyps in NAVIGATOR. PA876–PA876. 6 indexed citations
13.
14.
Hunter, Gillian, Rachael A. Powis, Ross A. Jones, et al.. (2016). Restoration of SMN in Schwann cells reverses myelination defects and improves neuromuscular function in spinal muscular atrophy. Human Molecular Genetics. 25(13). ddw141–ddw141. 30 indexed citations
15.
Powis, Rachael A., Evangelia Karyka, Penelope J Boyd, et al.. (2016). Systemic restoration of UBA1 ameliorates disease in spinal muscular atrophy. JCI Insight. 1(11). e87908–e87908. 69 indexed citations
16.
Hunter, Gillian, Sarah L. Roche, Eilidh Somers, Heidi R. Fuller, & Thomas H. Gillingwater. (2014). The influence of storage parameters on measurement of survival motor neuron (SMN) protein levels: Implications for pre-clinical studies and clinical trials for spinal muscular atrophy. Neuromuscular Disorders. 24(11). 973–977. 5 indexed citations
17.
Hunter, Gillian, Douglas J. Lamont, Maica Llavero Hurtado, et al.. (2014). Label-Free Quantitative Proteomic Profiling Identifies Disruption of Ubiquitin Homeostasis As a Key Driver of Schwann Cell Defects in Spinal Muscular Atrophy. Journal of Proteome Research. 13(11). 4546–4557. 38 indexed citations
18.
Hunter, Gillian, et al.. (2013). SMN-dependent intrinsic defects in Schwann cells in mouse models of spinal muscular atrophy. Human Molecular Genetics. 23(9). 2235–2250. 54 indexed citations
19.
Mutsaers, Chantal A., Douglas J. Lamont, Gillian Hunter, Thomas M. Wishart, & Thomas H. Gillingwater. (2013). Label-free proteomics identifies Calreticulin and GRP75/Mortalin as peripherally accessible protein biomarkers for spinal muscular atrophy. Genome Medicine. 5(10). 95–95. 30 indexed citations
20.
Hunter, Gillian. (1977). Follicular Bowen's disease. British Journal of Dermatology. 97(s15). 20–20. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Verena Matejas Breakdown of academic impact, for papers by Chantal A. Mutsaers Breakdown of academic impact, for papers by Robert Fey Breakdown of academic impact, for papers by Silvia Spena Breakdown of academic impact, for papers by Florian Barthélémy Breakdown of academic impact, for papers by Miko Valori Breakdown of academic impact, for papers by Greet Dijkman Breakdown of academic impact, for papers by Cristina Villanueva‐Mendoza Breakdown of academic impact, for papers by Beate Mitulla Breakdown of academic impact, for papers by Eliza A. Gaylord
Rankless by CCL
2026